Production (Stage)
Brainstorm Cell Therapeutics Inc.
BCLI
$1.22
-$0.02-1.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 111.04% | -85.62% | -88.15% | 363.77% | -65.02% |
| Total Receivables | 157.69% | 23.53% | -39.39% | -64.52% | -40.91% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 36.78% | -75.36% | 183.64% | -15.59% | -31.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 85.23% | -79.73% | -76.35% | 214.59% | -57.02% |
|
|
|||||
| Total Current Assets | 85.23% | -79.73% | -76.35% | 214.59% | -57.02% |
| Net Property, Plant & Equipment | -45.15% | -40.88% | -64.63% | -63.03% | -61.65% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -100.00% | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.99% | -0.48% | 866.67% | 804.55% | 778.26% |
| Total Assets | 6.66% | -56.46% | -64.36% | -1.11% | -57.47% |
|
|
|||||
| Total Accounts Payable | 44.93% | 22.73% | 17.24% | 2.89% | -39.89% |
| Total Accrued Expenses | -15.41% | -50.08% | 1,273.02% | 697.78% | 271.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -24.66% | -8.96% | -56.36% | -58.20% | -57.67% |
| Total Finance Division Other Current Liabilities | 109.71% | 42.57% | 1.75% | 0.95% | -13.49% |
| Total Other Current Liabilities | 109.71% | 42.57% | 1.75% | 0.95% | -13.49% |
| Total Current Liabilities | 59.58% | 15.10% | 12.04% | 0.00% | -34.46% |
|
|
|||||
| Total Current Liabilities | 59.58% | 15.10% | 12.04% | 0.00% | -34.46% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -76.17% | -74.55% | -82.90% | -79.57% | -76.72% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -24.75% | 103.63% | -- | -- |
| Total Liabilities | 23.94% | 5.85% | -2.20% | -4.35% | -30.00% |
|
|
|||||
| Common Stock & APIC | 4.31% | 4.15% | 5.20% | 6.41% | 7.48% |
| Retained Earnings | -5.08% | -5.41% | -6.79% | -6.12% | -7.66% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -34.36% | -59.82% | -134.59% | 9.14% | -14.67% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -34.36% | -59.82% | -134.59% | 9.14% | -14.67% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -34.36% | -59.82% | -134.59% | 9.14% | -14.67% |
|
|
|||||